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Errors in corticospinal axon guidance in mice lacking the neural
cell adhesion molecule L1
N.R. Cohen*, J.S.H. Taylor*, L.B. Scott†, R.W. Guillery‡, P. Soriano§
and A.J.W. Furley¶¥
Background: Neural cell adhesion molecules of the immunoglobulin
superfamily (IgCAMs) have been implicated in both the fasciculation and
guidance of axons, but direct genetic evidence of a role for neural IgCAMs in
axon guidance in vertebrates is lacking. The L1 subfamily of vertebrate neural
IgCAMs function as both homophilic and heterophilic receptors for a variety of
cell-surface and extracellular ligands and may signal through intracellular
kinases or by recruitment of the fibroblast growth factor receptor. L1 itself has
been implicated in many neural processes and is expressed widely in the
embryonic and adult nervous systems. In humans, mutations in the L1 gene are
linked with a spectrum of brain disorders, including loss of the corticospinal
tract, but the mechanistic basis for these disorders is unknown. 
Results: We show that mice that do not express L1 have defects in the
guidance of axons of the corticospinal tract, a major motor control pathway
projecting from the cortex to the spinal cord. Although the pathway to the
caudal medulla appears normal, a substantial proportion of axons fail to cross
the midline to the opposite dorsal column as normal. In adults, this results in a
reduced decussation and in large numbers of axons projecting ipsilaterally.
There is also a varying, but reduced, number of corticospinal axons in the dorsal
columns of the spinal cord. These do not project beyond cervical levels. We
show that these are defects in axon guidance, because they arise during the
early stages of the development of the decussation. The presence of a ligand
for L1, CD24, specifically at the point of decussation suggests a mechanism in
which L1 functions to guide corticospinal axons across the midline.
Conclusions: L1 function is necessary for the guidance of corticospinal axons
across the pyramidal decussation in mice. Some of the defects in the
corticospinal tract of humans with mutations in L1 could be due to errors in
axon guidance at the pyramidal decussation.
Background
To establish the functioning brain, neurons must become
connected. Connections are formed by the extension of
processes, termed axons, between neurons and their
targets. Axons find their targets by sensing and responding
to guidance cues present in their environment as they
extend. As the nervous system increases in complexity
during development, the surfaces of other axons and glial
cells become the predominant environment of extending
axons. Thus, on axonal surfaces, one would expect to find
both molecules that function as receptors for cues and
molecules that form the cues themselves. Whereas mol-
ecules that have one or other of these distinct roles are
found, it is perhaps not surprising that many of the mol-
ecules found on the axonal surface have characteristics
that suggest that they may function both as cues and as
receptors. One such class of molecules is the family of
neural cell adhesion molecules of the immunoglobulin
superfamily (IgCAMs). The archetypal member of this
family, NCAM, is able to bind to itself homophilically,
and numerous experiments in vitro and, more recently,
genetic experiments with the Drosophila homolog, Fasci-
clin II, suggest that this CAM regulates axon–axon fascic-
ulation by cross-linking axonal surfaces [1,2]. Neither in
Drosophila nor in mice, however, have genetic experi-
ments revealed a role for NCAM in the directional guid-
ance of axons [2–6].
It has been suggested that other neural IgCAMs are
involved in specific guidance events. The L1-like CAMs
form a subfamily of IgCAMs characterised by
immunoglobulin-like domains and fibronectin type III
domains [7]. Some of these bind homophilically and have
been implicated in regulating axon–axon interactions.
Recent studies have indicated, however, that these mol-
ecules can act as receptors for other members of the family
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and for a variety of other cell-surface and extracellular
ligands [8,9] . In addition, there is evidence that L1-like
CAMs signal through intracellular kinases [10–12] and by
recruitment of the fibroblast growth factor receptor sig-
nalling pathway [13]. Highly regulated spatial and tempo-
ral changes in the localisation of L1-like CAMs can be
found coincident with changes in axon-pathfinding trajec-
tories. For example, in the rat spinal cord, the cell-surface
glycoprotein TAG-1 is replaced by L1 on commissural
axons coincident with a change from extension in the
transverse axis to extension in the longitudinal axis as
these axons cross the midline at the floor plate [14]. In the
chick, reagents that perturb interactions between the
chick homologue of TAG-1, axonin-1, and the L1-like
molecule, NrCAM, cause commissural axons to turn into
the longitudinal axis prematurely, probably because of the
failure of an interaction between the axons and the
midline cells of the floor plate [15,16].
L1 itself has been implicated in many neural processes and
is distributed widely during development and in the adult
nervous system [8]. A detailed analysis of the effects of loss-
of-function mutations in the genes encoding L1 or other
L1-like molecules has, however, not been reported for ver-
tebrates. Mutations have been found in human L1 and are
linked to a spectrum of brain disorders, including hydro-
cephalus, mental retardation and spastic paraplegia [17].
The more severe of these syndromes are characterised by
the absence of specific axon tracts. It is not known,
however, whether this is due to defects in axon pathfinding
or to defects in axonogenesis or neurogenesis. Here, we
show that a mutation introduced into the gene encoding
mouse L1 has a highly specific effect on the guidance of
axons of the corticospinal tract at the pyramidal decussation. 
Results and discussion
Mice lacking L1 are viable
The mouse L1 gene was mutated in embryonic stem cells
by replacement of the exons encoding the sixth
immunoglobulin-like domain with a selectable drug-resis-
tance cassette (Figure 1a). Four targeted clones, identified
using the polymerase chain reaction (PCR) and then con-
firmed by Southern blotting (Figure 1b), were used to
generate germline chimaeras. As L1 is X-linked, hemizy-
gous males L1–/Y carrying the mutated allele arise in the
first generation. Such males were born at a slightly
reduced frequency of about 40% (84 were recovered from
a total of 211 males) but survived to late adulthood (>18
months). Initially, L1– mutant males were about 60% of
the body size of their wild-type littermates but, in adult-
hood, they reached ≥ 80% of the size of their littermates.
Adult L1– mutant mice had ‘sunken’ and lacrimous eyes,
often with a discharge. With age, on a 129Sv congenic
agouti background, patches of black fur appeared on their
backs, and they had abnormally long hind-paw toenails
(4–5mm). Dragging of hindlimbs was also noted in some
individuals more than 12 months of age. Some individuals
were able to breed but most were effectively sterile,
although histological analysis of the testis revealed the
presence of germ cells.
To determine whether this mutation prevents the synthe-
sis of the L1 protein, we analysed adult brain lysates by
immunoblotting using two different antibodies to L1
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L1 gene disruption. (a) Map of part of the L1 genomic locus and
targeting vector. TK, MC1TKpA cassette; neo, PGKneobpA cassette.
Only the approximate positions of exons encoding the sixth
immunoglobulin-like domain of L1 are shown (black boxes). Bg, BglII;
H, HindIII; B, BamHI; R1, EcoRI; RV, EcoRV; X, XhoI. The position of
the 5′ probe is indicated. (b) Southern blot analysis using the 5′ probe
on EcoRV-digested tail DNA from heterozygous females (+/–), or
hemizygous (–/Y) or wild-type males (+/Y). (c) Western blot analysis of
whole-brain lysates from hemizygous (–/Y) or wild-type (+/Y) males
using a rabbit polyclonal antibody to L1. Note the absence of the
approximately 200 kDa wild-type protein [18] and of any novel
immunoreactive products in the lysate from mutant mice. Longer
exposures confirmed this finding (data not shown), although we cannot
rule out the possibility that minor aberrant products are obscured by
background reactivities.
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(Figure 1c and data not shown). In lysates from mutant
mice, there was a complete absence of the normal (approx-
imately 200 kDa) L1 protein [18] and we were unable to
detect novel immunoreactive products at lower molecular
weights. We were also unable to detect L1 in tissue sec-
tions from mutant mice (see below). These data suggest
that the deletion results in a null mutation.
L1 is necessary for the guidance of corticospinal axons at
the pyramidal decussation
Using standard histochemical techniques such as silver
staining, we were unable to detect obvious morphological
defects in major central and peripheral nervous system
structures where L1 is normally present [14,19–23]. Never-
theless, the defects in the hindlimb function of L1-hemizy-
gous males, the localisation of L1 on corticospinal axons
[19], and the fact that mutations in human L1 are associated
with defects in the corticospinal tract [17,24,25], prompted
a detailed examination of the corticospinal pathway.
In adult mammals, the corticospinal tract connects the sen-
sorimotor cortex with motor neurons and interneurons of
the spinal cord, allowing higher control of limb movement,
and, in particular, fine manipulative control [26]. Axons
from cells in layer V of the cortex grow, via the internal
capsule, to the cerebral peduncles, reaching the caudal
hindbrain at embryonic day 18, E18 (N.R.C. and J.S.H.T.,
unpublished observations; for rat, see [27]). At this point,
the majority (>95% in rats and mice) of these and later
arriving corticospinal axons turn dorsally and cross the
midline, passing from the ventral pyramid to the dorsal
columns, to form the pyramidal decussation. The route
taken by corticospinal axons is illustrated diagrammatically
Figure 2
Diagram of the caudal hindbrain and rostral spinal cord, showing the
route taken by corticospinal axons through the pyramidal decussation.
Axons (green) descend through the hindbrain in the ventral pyramid (P)
until they reach the level of the hypoglossal nuclei (XII) close to the
hindbrain–spinal cord boundary. At this point, they turn dorsally from the
longitudinal axis into the transverse axis, cross the midline and extend
dorsally to the dorsal column (DC), thus forming the pyramidal
decussation. At the dorsal column, they turn again to the longitudinal axis
and extend caudally in the dorsal column of the spinal cord. For clarity,
axons descending from the right hand cortex are shown as a broken line.
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Figure 3
Tracing of the corticospinal tract at P3.
Coronal sections through the pyramidal
decussation (PD) and upper cervical spinal
cord (SC) of a control (+/Y) mouse, (a,c), and
an L1– mutant (–/Y) (b,d) after unilateral
injection of WGA–HRP tracer into the cortex.
During normal development (a), axons
(labelled with HRP in this figure) pass from
the pyramid (P) across the midline (black
arrow), intersecting with the population from
the other side of the brain (unlabelled,
indicated by small white arrowheads), then arc
dorsally to the dorsal columns (DC), giving off
fine terminals to the dorsal column nuclei
(large white arrowhead). In the L1– mutant (b),
axons pass from the left pyramid (P) directly
over the midline and into the pyramid on the
opposite side (white arrow). Although there is
major disruption of the decussation, some
fibres do succeed in crossing the midline and
have grown towards the dorsal columns (DC).
In the upper cervical dorsal columns of the
spinal cord, shown with an arrowhead in (c,d),
corticospinal axons are present in controls (c),
but absent in the L1– mutant (d).
in Figure 2, and Figure 3a shows a section through the
pyramidal descussation at postnatal day 3 (P3), when the
majority of axons are growing through it [27].
To trace the corticospinal tract axons in normal and L1-
mutant mice, we used wheat-germ agglutinin conjugated
to horseradish peroxidase (WGA–HRP) as an anterograde
tracer. In all three cases of L1– mutant males that were
successfully labelled (see Materials and methods) at
P3–P5, corticospinal axons projected normally to the
medulla, but at the decussation only very few axons,
rather than the majority, had grown to the contralateral
dorsal columns (compare Figure 3a with Figure 3b).
Instead, many axons turned ventrally at the midline and
entered the contralateral pyramid. In one case, these aber-
rant axons turned rostrally in the contralateral pyramid,
projecting back towards the midbrain. In the other cases,
the aberrant axons could not be traced beyond the decus-
sation. In contrast to the normal projection (Figure 3c), no
labelled axons were apparent in sections caudal to the
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Figure 4
Tracing of the corticospinal tract in adults. Coronal sections through
the pyramidal decussation and upper cervical spinal cord of an adult
control (+/Y) mouse, (a,d), and L1– mutant (–/Y) mouse (b,c,e) after
unilateral cortical HRP injection. In the control (a,d), axons (HRP-
labelled) take their normal course from the pyramids (P), across the
midline (arrow), to the dorsal columns (DC, and white arrowhead in
(d)). In the mutant (b), there is disruption of the normal pattern of
decussation with many axons failing to cross the midline, and instead
following a pathway that is the mirror image of and symmetrical to the
normal one, to reach the dorsal columns (DC). Another mutant (c)
shows axons passing both ipsilateral and contralateral at the
decussation (arrowheads). In the dorsal columns, the disruption of the
decussation is reflected in a change in the normal large crossed
projection (d), to a bilateral and much reduced projection
(arrowheads, (e)).
decussation in mutant mice, either dorsally or ventrally
(Figure 3d). These observations show that major axon
guidance defects occur at the developing pyramidal
decussation in L1– mutant mice.
Corticospinal axons fail to project to the spinal cord in
adult L1– mutant mice
Normal development of the corticospinal tract takes place
over a period of several days and many more cortical axons
project into the spinal cord than ultimately survive to
innervate it [28]. In the L1– mutant males, therefore, early
errors in pathfinding could be rescued by later descending
axons following the minority of axons that do project cor-
rectly across the decussation. To determine whether such
rescue does occur, we traced the projection of the corti-
cospinal tract in adult animals. In all of nine cases of adult
L1– mutant males labelled successfully, corticospinal
axons projected normally to the medulla (Figure 4b,c). At
the level of the decussation, although there was no evi-
dence of the aberrant ventral projection seen in the post-
natal mutants, a substantial proportion of axons failed to
cross the midline and, instead, passed ipsilaterally into the
dorsal columns (Figure 4b,c). Thus, in L1– mutant males,
there were labelled axons in both dorsal columns, but the
total number of these axons caudal to the decussation was
reduced (Figure 4e, compare with d). Although the
numbers of misdirected axons was variable—in one case
the decussation was near normal —the presence of aber-
rant ipsilaterally projecting axons was consistent. More-
over, we found no HRP labelling more caudally than the
cervical spinal cord in any of the L1– mutant mice,
whereas we were able to detect such labelling throughout
the spinal cord in controls. These observations suggest
that late-growing axons continue to make pathfinding
errors at the pyramidal decussation.
Errors in axon pathfinding are not apparent at other
commissural pathways
To test whether the corticospinal decussation was the
only L1-expressing commissural pathway to be affected,
we examined the corpus callosum [29], optic chiasm [21]
and spinal commissural projection [14] of the L1– mutant
mice. Unilateral injections of smaller amounts of
WGA–HRP into the cortex in two mutant mice revealed a
normal corpus callosum and descending corticofugal pro-
jection to the thalamus and internal capsule (Figure 5a).
WGA–HRP was injected into the optic tract of a further
two adult mutant mice to retrogradely label retinal gan-
glion cells and their axons as they passed through the
optic chiasm. The distribution of labelled axons in the
optic chiasm was the same in mutants and controls,
showing, in addition to the majority of crossing axons, a
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Figure 5
Analysis of commissural axon pathways. (a) A
coronal section through cerebral hemispheres
of an adult L1– mutant showing the HRP-
injection site (white arrowhead) and labelled
axons within the corpus callosum at the
midline (arrow). The corticofugal projection to
the thalamus and internal capsule is also
labelled and exits to the left (black
arrowhead). (b) Coronal section through the
optic chiasm of an adult L1– mutant mouse,
showing HRP-labelled axons of the crossed
projection passing from the left to the right of
the figure and the smaller uncrossed
projection (arrowheads) entering from the
ipsilateral optic nerve on the left. (c) The
normal distribution and morphology of HRP-
labelled retinal ganglion cells within the
temporal crescent of the retina, ipsilateral to
the injection site in an adult L1– mutant. (d)
Section of the spinal cord of an E11.5 control
(+/Y) mouse immunostained with anti-L1
monoclonal antibody 324, showing the
expression within the ventro-lateral columns
and dorsal root ganglion (DRG) axons. (e)
Identical section to that in (d) but from an L1–
mutant littermate showing no L1 staining. Anti-
TAG-1-stained spinal cord sections from (f)
an E11 control mouse (g) an L1– mutant
showing identical TAG-1 expression in axons
forming the ventral commissure in the base of
the floor plate and axons of the dorsal root
ganglia and the motor roots.
normal uncrossed projection turning lateral to the midline
from the ipsilateral optic nerve (Figure 5b). In flat-
mounted retinae, the tracer also revealed the cell bodies
of the uncrossed axons in the temporal crescent of the
ipsilateral retina, where their distribution and number
were indistinguishable from those of controls (Figure 5c).
In spinal cord sections of mutant and control mice at E11,
there was an apparently normal spinal commissural pro-
jection, as judged by staining with antibodies to the cell-
surface glycoprotein, TAG-1 [14] (Figure 5d–g). In
summary, with the exception of the corticospinal decussa-
tion, no other abnormality of decussation was found in the
mutant mice.
L1 ligands are localised at the pyramidal decussation
Our evidence suggests that, in mice, L1 is involved in a
specific phase of axon pathfinding by the corticospinal
axons, namely the crossing of the pyramidal decussation.
L1 could function in one or more possible ways in corti-
cospinal axon guidance. L1 is normally localised on corti-
cospinal axons both before their arrival at the decussation
and as they pass through it [19] (Figure 6a,b). Therefore,
in this system, L1 may act as a receptor for cues at the
decussation, rather than in modulating fasciculation
between corticospinal axons, as has been suggested for
the spinal commissural axons [14]. The early pathfinding
errors seen in L1– mutants suggest that axons have failed
to respond to a guidance cue present at the midline
(Figure 3b). One such cue may be the L1 ligand CD24
[30], which we have found to be highly localised along the
ventral midline at the point of decussation (Figure 6c).
CD24, or nectadrin, is a lipid-anchored proteoglycan
known to modify L1 signalling [30] and to inhibit neurite
outgrowth [31]. The presence of CD24 at the ventral
midline normally may prevent L1-positive axon growth
from one pyramid directly into the other, hence the
failure of this process in the absence of L1 (Figure 3b).
Alternatively, CD24 may be involved in an interaction
between the advancing growth cones and midline glial
cells which allows growth of corticospinal axons across the
midline. This might be comparable to the situation in the
spinal cord, where an interaction between axonin-1 on
spinal commissural axons and an L1-like molecule,
NrCAM, on floor-plate cells modifies the response of
commissural growth cones to a midline inhibitory cue,
allowing axons to cross [15,16]. Thus, in the corticospinal
tract, failure to respond to CD24 at the midline might
leave corticospinal axons confined to the mirror-symmet-
rical axon tracts on the ipsilateral side of the brain (for
example, Figure 4b,c). It is interesting to note that block-
ade of the axonin-1–NrCAM interaction in the spinal cord
also leads to a variable proportion of axons — never more
than 50% — failing to cross the midline [15,16].
It is also possible that L1-mediated fasciculation may play
a role in guidance through the pyramidal decussation.
Unrelated axon tracts present at the site of the future
decussation may form a guiding ‘scaffold’ on which corti-
cospinal axons can fasciculate. The internal arcuate axons
of the dorsal-column–medial-lemniscal system decussate
in the caudal medulla at E14, before the arrival of corti-
cospinal axons. These axons themselves express L1
(Figure 6a,b), but only after they have grown through the
decussation at a time (E17) just before the arrival of the
corticospinal axons in the medulla at E18 (N.R.C. and
J.S.H.T., unpublished observations). Thus, the ability of
L1 to bind homophilically [32] may allow corticospinal
axons to fasciculate with the internal arcuate axons to
cross the midline. In the absence of L1, CS axons may
instead follow other pathways, which include the opposite
pyramidal tract and the adjacent internal arcuate axons,
giving the patterns seen in the mutants (Figures 3 and 4).
It is unlikely, however, that contact with the internal
arcuate axons initiates the decussation of corticospinal
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Figure 6
Localization of L1 and CD24 in the pyramidal
tract. (a,b) Immunostained coronal sections
through the mid-medulla of a P1 mouse
showing anti-L1-stained axons in the pyramids
(P) and pyramidal decussation (arrow in (b))
and the internal arcuate axons (arrows in (a)).
(c) Coronal section at the point of
decussation in an E18 embryo showing the
staining pattern of CD24 in the midline
between the two pyramids (P). Where the
unstained bundles of pyramidal axons cross
the midline (arrows), CD24 is localized just
adjacent to the axons (close to the
arrowheads).
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axons because the internal arcuate decussation extends
rostral to the point at which the CS decussation begins
(Figure 6a).
A third possibility is that subsets of cortical axons act to
pioneer a path through the decussation, independent of
L1 function, and that later-arriving axons follow these pio-
neers by L1-mediated fasciculation. The fact that some
early axons project apparently correctly through the
decussation (Figure 3b) supports this idea. The appear-
ance in the adult of axons that project to the dorsal
columns via aberrant ipsilateral pathways (Figure 4b,c),
however, complicates this simple interpretation. Indeed,
the apparent difference in the errors seen at P3 compared
with those seen in the adult suggest that several different
mechanisms may be involved, each active at different
stages of development. To distinguish between these
possibilities will require a detailed anatomical study of the
sequence of developmental changes occurring in normal
and in L1– mutant mice.
Pathfinding defects in L1– mutant mice relate to
abnormalities found in humans with mutations in L1
The aberrations in the corticospinal tract that we have
seen in the L1– mutant mice may help to elucidate some
aspects of the defects seen in humans with mutations in
the L1 gene [17]. In the most severe of such cases, a
condition known as hydrocephalus resulting from a
blockage of the aqueduct of Sylvius (HSAS), the most
consistent neuropathological finding is disruption or
absence of the corticospinal tract [24]. Our results indi-
cate that, in mice, abnormalities in navigation of the
pyramidal tract occur primarily at the decussation
leading to a failure of a proportion of corticospinal axons
to reach their targets. We have not, however, observed
the severe reduction in the pyramidal tract reported in
some HSAS cases [17,24], nor have we found hydro-
cephalus, nor changes in the corpus callosum, frequently
missing in HSAS patients [17]. It is unclear why there
appear to be more profound and varied effects in the
human mutations, but these may reflect differences in
the precise nature of the mutations and in the pattern of
corticospinal decussation between humans and rodents.
Nonetheless, our observation that few, if any,
corticospinal axons project below the cervical spinal cord
in L1– mutant mice can readily be related to the motor
disturbances found in the milder human L1-linked syn-
dromes, MASA syndrome (Mental retardation, Aphasia,
Shuffling gait, Adducted thumbs) and type I spastic
paraplegia (SPG1) that include shuffling gait, adducted
thumbs and lower limb spasticity [17]. The recent
observation that mutations in the gene encoding the cell
adhesion molecule, neuroglian, in Drosophila affect
motor axon guidance [33] suggests some conservation of
the function of L1-like molecules in the establishment
of connections in motor control systems.
Conclusions
Our findings indicate that a deletion in the gene encoding
the neural cell adhesion molecule L1 produces a disrup-
tion of axon navigation specifically at a point of decussa-
tion where identified ligands of L1 could be acting as
guidance cues. This defect in axon guidance results in
failure of axons to reach their targets, thus implicating
failure to establish appropriate connectivity as a potential
factor in human neurological syndromes.
Materials and methods
Derivation of mutant mice 
The targeting construct includes a 4.5 kilobase (kb) BglII–BamHI frag-
ment derived from the L1 locus, a BamHI–XhoI (blunted) fragment
including MC1TKpA and PGKneobpA cassettes inserted in the same
transcriptional orientation as the L1 gene, and a 1.6 kb EcoRI
(blunted)–EcoRV L1 genomic fragement. The linearised vector was
introduced into AB1 ES cells by electroporation, and neo-resistant
cells were selected in 300 µg/ml G418 and screened for homologous
recombination by PCR as described previously [34] using a 5′ primer
that anneals to the neo sequence (5′-TGGCTACCCGTGATATTGCT-
3′) and a 3′ primer that anneals to the L1 sequence downstream of the
EcoRV site (5′-GGACTGGGACACCTTAGGGG-3′). Homologous
recombination was further verified using a 0.6 kb PstI–NcoI genomic
fragment 5′ of the targeted locus (denoted as ‘probe’ in Figure 1a) on
EcoRV-digested genomic DNA (wild type 14 kb, mutant 9.3 kb; Figure
1b) or a 1.0 kb SacI probe 3′ of the targeted locus on BglII-digested
genomic DNA (wild type 13 kb, mutant 9 kb) or HindIII-digested DNA
(wild type 5.7 kb, mutant 6.9 kb) (data not shown). Probing the blots
with a probe derived from the neo sequence confirmed the insertion of
a single gene. Lysates from whole brain were prepared by homogenisa-
tion in cold RIPA buffer. Proteins were separated on 7.5% acrylamide
gels by polyacrylamide gel electrophoresis, blotted to nitrocellulose by
routine procedures, and probed with monoclonal (74-5H7) or affinity-
purified rabbit polyclonal antibodies, generously provided by Vance
Lemmon and Melitta Schachner, respectively. Similar phenotypes were
observed from four independently targeted clones as well as on 129Sv
congenic or 129Sv × C57BL6/J F1 hybrid genetic backgrounds. 
Axonal tracing
Multiple injections of 1 µl 5% WGA–HRP mixed with 30% HRP were
made unilaterally into the cortex or optic tract of mice anaesthetised
with either low doses of halothane for adults, or ether for neonates.
Mice with the L1 mutation have proved to be sensitive to our normal
anaesthetic regimes (Hypnorm/hypnovel) and many died during
surgery. Of the 38 adult mutant mice that survived anaesthesia and
injection, nine were found to be adequately labelled to be included in
the analysis. Of the 26 neonatal mice that survived the procedure, only
three were found to be adequately labelled. After 17–48 h, animals
were perfused, and 100 µm cryosections were cut and stained accord-
ing to the tetramethyl benzidine method [35]. Retinae were flat-
mounted and stained by the Hanker–Yates method [36].
Immunohistochemistry
Immunohistochemical analysis was carried out on 20 µm cryosections
using anti-TAG (4D7; [14]), anti-L1 (324; Boehringer Mannheim) and
anti-CD24 (MCA450; Serotec) monoclonal antibodies and visualised
using fluorescent secondary antibodies as described [14].
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